Inhibition of AcSDKP leads to disruption of renal cellular metabolism and activation of interstitial transformation, leading to severe fibrosis in the diabetic kidney (Srivastava et al., 2020b). This evidence concerns the gene TMSB4X and urogenital neoplasm.